· Leading the Abbott Nutrition Division ($150Mio) team of more than 90 people in the areas of sales, KAM, Access, Tenders (reimbursed & out of pocket business): Endocrinology, Oncology, Internal Medicine, Surgery, Gastroenterology specialties, as well as wholesalers & e-commerce · Managing the Spanish full P&L. · Member of the Spain Board of Directors

· Leading the Biosimilar Commercial Sandoz divisions ($200Mio): In-line (Oncology and Endocrinology) and Immunology franchise (Rheumatology, Dermatology and Gastroenterology), as well as Multiple Sclerosis (CNS), Transplant, Hospital (Anti-infective, HIV, and Oncology), Market Access (Regional Access & Key Account Management), and Governmental Affairs. · Managing the complete P&L to ensure consistent financial over delivery · Leading Sales, Marketing, Public Offering (Tendering), Market Access & Governmental Affairs teams (60 people) · Member of the European CLT (Commercial Leadership Team) for the Marketing, Sales, and Access areas · Member of the Sandoz Iberia Board Team · Granted with different awards such us Sandoz innovative solution award, European Best Launch (eg. Teriflunomide), Novartis group innovation award, Sandoz Pioneer for growth award, Novartis innovation and courage award (One Transplant), Correo Farmaceutico award as best initiative for patient centric approach

· Leading the national organization of 90 people on the areas of Sales & Marketing · Managing P&L to ensure consistent financial over delivery · Contributing as a IVBL leader to develop with the HEMAR, MA and MAF departments a sustainable growth in the areas we work in · Taking an acting roll in the recruitment process in Janssen Spain, working directly with the HHRR department, interviewing all the sales and marketing positions coming to the Company

· P&L Management LifeScan 36M $ · Appointed to the Western-Southern LifeScan Executive Board and to the Iberia MD&D Council & Iberia Compliance Committee · Led the national organization of 51 members on the areas of Sales, Admin, Sales Analytics, Marketing, Medical Affairs, Distribution & Government Affairs/Market Access. · Institutionalized (at a Regional level) the Company Force Effectiveness (CFE) as a new concept on how different departments should work together in order to achieve company target (cross-functional teamwork) · Sales Force Effectiveness benchmark country of EMEA (Panta Rhei Project) carried out by an external consultancy company (ZS Associates) · Created and led an EMEA wide benchmarked Market Access organization that ensured wide accessibility and consistent reimbursement price through a holistic strategic approach to Payors, KOLs, Key Decision Makers & Patient Associations Developed strategy to deal with INGESA national tender that saved around 50MM $ MNI over 2 years & other regional tenders in which LifeScan was granted access with the highest reimbursement price · Led and developed locally a two prong strong Health Economics evidence through different scientific studies to protect the category & to support LifeScan cost-effectiveness solutions with the support of Medical Affairs & Strategic Affairs · Led P&L to ensure consistent financial over delivery: Extra MNI delivered 4 years in a row · Developed and nurtured talent: 2 sales reps&1Market Access specialist developed into RBMs, 1 sales rep into Market Access Specialist and 1 RBM into BUM of Greece & Turkey · Led a Credo Turnaround: from lowest Credo scores (in LifeScan EMEA and MD&D Iberia) of 53% when I joined the team in 2008 to 90% through constant improvements every year. Current results are strongly above EMEA LifeScan & MD&D EMEA · Granted Leadership Award in 2011 · Out of 5 years: Elected EMEA Country of the year in 2008 & 2012 and Finalist Country of the year in 2009 & 2011 Jan 2008 – Dec 2009: National Sales Director · Member of the EMEA Leadership Team that defines the commercial strategy for the region (Sales Force Effectiveness KPI´s, Channel Management, Value Proposition Dossier for new product launches) · Turnaround on commercial execution: Enhanced commercial execution that led toa4consecutive years of market share gain. 50% of the sales team had to be replaced · Led a flawless Sales Force Effectiveness Execution to ensure maximum Sales Rep Efficiency & Effectiveness in order to compensate our smaller sales force size by revamping segmentation and frequency. Independent and external market research company shown in its report that LifeScan share of voice on customer´s mind was the highest in the category despite having the smallest sales force in the category · Promote a holistic project approach with other J&J Companies to treat Diabetic patients in Secondary Care in order to gain Market Share on a competitor free environment (Pilots with Cordis Cardio and Cordis Endo) · Developed a Sales Rep dashboard with both quantitative & qualitative KPIs to ensure constant Sales rep activity monitoring by RBMs and myself that was later on adopted at EMEA level · Led Tender Management project to improve outcome with regional Health Care Authorities and other Stakeholders , I led the project in order to get advantage in tenders (better scoring) an get a preferential access for our products and solutions

· Direct report to Janssen Commercial Director · Led Oncology/Hematology commercial team of 20 Sales Reps+3RBM´s (Regional Bussines Managers) and systematically over delivered on my sales targets. Product portfolio Eprex/Procrit, Leustatatin/Cladribine and launched Velcade · 2 out of 3 of the RBM´s were promoted from the sales reps · Awarded EMEA prize for the best drug performance (Velcade) for highest consumption per million inhabitants Feb 2000 – Sep 2002: Regional Sales Manager · Turnaround in the north of Spain · Led Oncology commercial team of 8 Sales Reps and transformed the country´s lowest performing region (lowest Market Share & Growth) into the highest performing one (Higher Market share & Fastest Growth): over 50% market share in the category Feb 1999 – Feb 2000: Sales Representative (specialized care) · Launched Eprex (Epoetin Alfa) on Oncologist, Hematologist and Radiology Oncologist care as well as in Hospital Pharmaceuticals in Asturias, Cantabria and León · Achieved 100% growth in Sales by a strategic and targeted approach on major Hospital Pharmacies and partnering with KOLs and as a consequence I was promoted to Regional Sales Manager role

· Visited Primary Care Doctors (GP´s) and Secondary Care Physicians of different pathologies (Pain Units, Gynecology, Dermatology, Internal Medicine, Traumatology, and Rheumatology) in Asturias (Region located in the North of Spain) · Launched with extreme success Durogesic (Fentalin patch) and as a consequence I was promoted to specialized care

· Lead a commercial team responsible to gain new customers and maintain existing customer base · Responsible of a broad line of products such as investment funds, life insurance, retirement funds …